0001837607 2026-02-06 2026-02-06 0001837607 1 2026-02-06 2026-02-06 iso4217:USD pure shares S-3 S-3 EX-FILING FEES 0001837607 AEON Biopharma, Inc. N/A N/A S-3 AEON Biopharma, Inc. false Equity Class A Common Stock, par value $0.0001 per share true 51292953 1.06 54370530.18 0.0001381 7508.57 54370530.18 7508.57 0.00 0.00 7508.57 Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of Class A common stock, par value $0.0001 per share (the "Common Stock"), of AEON Biopharma, Inc. that become issuable by reason of any stock dividend, stock split, recapitalization, or other similar transaction without receipt of consideration. (2) Represents an aggregate of 51,292,953 shares of Common Stock, consisting of: (i) 12,185,835 shares of Common Stock, (ii) up to 17,818,460 shares of Common Stock issuable upon the exercise of pre-funded warrants, (iii) up to 14,706,829 shares of Common Stock issuable upon the exercise of common stock warrants and (iv) up to 6,581,829 shares of Common Stock issuable upon the exercise of true-up warrants. (3) Proposed Maximum Offering Price Per Share is estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act based upon the average of the high and low prices for the Common Stock as reported on the NYSE American on February 6, 2026.